Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field Ablation ...

Field Medical announced the presentation of clinical data from the first-in-human study of its FieldForce pulsed field ...

The medical device company presented latest clinical findings from its Field PULSE study at the atrial fibrillation symposium ...

Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field AblationCARDIFF ...

Atrial fibrillation, or A-fib, is becoming more common, but doctors say treatments are improving. The condition is a quivering or irregular heartbeat that can lead to blood clots, stroke and ...

Though its often harmless, the condition called PFO can be life-threatening. Learn about patent foramen ovale.

Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...

JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the presentation of four ...

American Stroke Association International Stroke Conference 2026 annual awards go to 11 stroke researchers for science, brain health contributions.

Kite, a Gilead Company , today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the previous ...

Eleven top scientists in stroke and brain health will be recognized for their individual exceptional professional ...

Conditions in Gaza’s displacement camps, malnutrition, and Israeli bans on the entry of medicines increase the risk.